within Pharmacolibrary.Drugs.N_NervousSystem.N02A_Opioids.N02AF01_Butorphanol;

model Butorphanol
  extends Pharmacolibrary.Drugs.ATC.N.N02AF01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N02AF01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Butorphanol is a synthetic opioid analgesic used for the management of moderate to severe pain, including pain associated with surgery, migraine, and cancer. It acts primarily as an agonist-antagonist at opioid receptors (agonist at kappa and partial agonist/antagonist at mu receptors). Butorphanol is approved and currently used in both human and veterinary medicine, with formulations available for intravenous, intramuscular, and nasal administration.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Ebner, L, et al., &amp; Cox, S (2022). Pharmacokinetics of butorphanol following intravenous and intramuscular administration in donkeys: A preliminary study. <i>Frontiers in veterinary science</i> 9 979794–None. DOI:<a href=&quot;https://doi.org/10.3389/fvets.2022.979794&quot;>10.3389/fvets.2022.979794</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36213418/&quot;>https://pubmed.ncbi.nlm.nih.gov/36213418</a></p></li><li><p>Paine, SW, et al., &amp; Hillyer, L (2020). The intravenous pharmacokinetics of butorphanol and detomidine dosed in combination compared with individual dose administrations to exercised horses. <i>Journal of veterinary pharmacology and therapeutics</i> 43(2) 162–170. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12838&quot;>10.1111/jvp.12838</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32012314/&quot;>https://pubmed.ncbi.nlm.nih.gov/32012314</a></p></li><li><p>Berlin, ER, et al., &amp; Mama, KR (2023). Pharmacokinetics of intravenous propofol in southern white rhinoceros (Ceratotherium simum simum) after intramuscular etorphine-butorphanol-medetomidine-azaperone. <i>American journal of veterinary research</i> 84(4) –. DOI:<a href=&quot;https://doi.org/10.2460/ajvr.22.12.0224&quot;>10.2460/ajvr.22.12.0224</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36812092/&quot;>https://pubmed.ncbi.nlm.nih.gov/36812092</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Butorphanol;
